Amanda Gordon
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 3
- Glioma Diagnosis and Treatment 2
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Hani Gabra (2 shared papers)David E. Parkin (2 shared papers)Gordon C. Jayson (2 shared papers)J. P. Paul (1 shared paper)Robert Louis Coleman (1 shared paper)Paul Austin Vasey (1 shared paper)Andrea Hay (1 shared paper)Stuart B. Kaye (1 shared paper)
- Journals
- Blood (6 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer (1 paper)Neurology (1 paper)The Oncologist (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Amanda Gordon
14 papers receiving 893 citations
Amanda Gordon's Hit Papers
Peers
Comparison fields: 5 of 58
- Reproductive Medicine 364
- Obstetrics and Gynecology 108
- Genetics 122
- Oncology 263
- Pathology and Forensic Medicine 115
Countries citing papers authored by Amanda Gordon
This map shows the geographic impact of Amanda Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Gordon more than expected).
Fields of papers citing papers by Amanda Gordon
This network shows the impact of papers produced by Amanda Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Gordon. The network helps show where Amanda Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma Hit paper breakdown → | 2004 | 501 |
| 2 | 2005 | 179 | |
| 3 | On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma | 2004 | 109 |
| 4 | 2013 | 41 | |
| 5 | 2021 | 33 | |
| 6 | Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma. | 1997 | 25 |
| 7 | 2024 | 14 | |
| 8 | 2020 | 12 | |
| 9 | 2010 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2009 | 2 | |
| 12 | 2011 | 2 | |
| 13 | 2011 | 1 | |
| 14 | 2013 | 1 |
About Amanda Gordon
Amanda Gordon is a scholar working on Genetics, Pathology and Forensic Medicine, Neurology, Reproductive Medicine and Oncology, having authored 14 papers that have together received 936 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (2 papers), Glioma Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Reproductive Medicine (364 citations), Obstetrics and Gynecology (108 citations), Genetics (122 citations), Oncology (263 citations) and Pathology and Forensic Medicine (115 citations). Amanda Gordon has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Hani Gabra, David E. Parkin, Gordon C. Jayson, J. P. Paul, Robert Louis Coleman, Paul Austin Vasey, Andrea Hay, Stuart B. Kaye, R. Atkinson and Mark W. Kieran. Their work appears in journals such as Blood, JNCI Journal of the National Cancer Institute, Cancer, Neurology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.